PatientDTC: At the Forefront of Patient Focused Drug Development Patients bring a unique perspective to each clinical trial. They see connections that can otherwise elude clinical scientists. They identify aspects of clinical protocols that may result in unforeseen consequences on clinical trial performance. Today, companies that fail to effectively incorporate the patients perspectives at multiple points along the drug development continuum, will lose out on producing the kinds of drugs patients want, need, and use. At PatientDTC we recognize the importance of organized patient advocacy, but we go deeper. We find and connect with the real patient, and bring their collective voice into the process. Through our collaborative efforts with clinical teams we deliver the following: Identification of research questions, outcomes, and comparators; Clinical trial design and recruitment strategy; Patient-centered Study Seminars that prepare sites for patient recruitment, adherence and engagement Regulatory review; participation in FDA meetings The patient perspective is reshaping the clinical trial process, and as industry pioneers, we help clinical teams develop a systematic approach to soliciting patients voices, and turning the findings into action-oriented initiatives that speed the clinical development process. PatientDTC was founded by industry leader Liz Moench, who has devoted her career in pharmaceuticals and lifesciences to putting patients first. As an industry maverick in patient centered innovation here are examples of her accomplishments: 1. 1st prescription drug campaign brought direct to consumers (1983) 2. 1st company devoted to clinical trials recruitment (MediciGroup aka MediciGlobal 1991) 3. 1st to develop & publish the recruitment funnel (1996) 3. 1st to utilize social media (Facebook) for clinical trials (2007) 4. 1st to conduct patient centered patient recruitment training for sites (2008)